Arena (ARNA) Will Need Lower Co-Payments, Broader Coverage for Belviq Success (VVUS)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Arena (ARNA): Eisai Discloses $199.50/Bottle Acquisition Cost of Belviq 10-mg Tabs
February 25, 2013 9:20 AM ESTArena Pharmaceuticals, Inc. (Nasdaq: ARNA) made the following filing with the U.S. SEC today:
On February 25, 2013, Eisai Inc. disclosed a wholesale acquisition cost of BELVIQ (lorcaserin HCl) of $199.50 for a bottle of 60 10 mg tablets.... More
Risks vs. Benefits of Bariatric Surgery Might Put Obesity Pills in Lime Light (ARNA) (VVUS) (OREX)
February 21, 2013 12:56 PM ESTObesity-pill makers might be seeing a little bit of upside following the release of a new study on bariatric surgery. The American Society for Metabolic & Bariatric Surgery said about 220,000 procedures were performed in the U.S. during 2009, presumably the most recent data available.
Data points to cost of... More
